换一批Optimizing management of sentinel lymph node limited residual tumor after neoadjuvant therapy for breast cancer:Balancing of act
摘要IntroductionThe accuracy of sentinel lymph node biopsy(SLNB)after neoadjuvant therapy(NAT)has been confirmed in clinical nodal stage 1(cN1)patients,and more patients could benefit from axillary surgery de-escalation after NAT(1,2).The 2021 St.Gallen International Consensus Conference raised a question"For patients who presented with a clinically negative axilla,can axillary radiation therapy(RT)replace axillary lymph node dissection(ALND)in selected patients with residual disease in the sentinel nodes",and 38％ of panelists supported RT replaced ALND in sentinel lymph node(SLN)-limited residual tumor after NAT(3).
更多相关知识
- 浏览1
- 被引0
- 下载1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
